A Bayesian cost-benefit approach to the determination of sample size in clinical trials.

A Bayesian cost-benefit approach to the determination of sample size in clinical trials.

Item
http://www.wikidata.org/entity/Q47283839
Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic reviewOptimizing Trial Designs for Targeted TherapiesOptimal alpha reduces error rates in gene expression studies: a meta-analysis approachSpecifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchersDecision-theoretic designs for small trials and pilot studies: A reviewSample size determination for cost-effectiveness trials.Value of information methods for assessing a new diagnostic test.Accounting for between-study variation in incremental net benefit in value of information methodology.Optimal sample size determinations from an industry perspective based on the expected value of information.A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.An optimization approach to calculating sample sizes with binary responses.Bayesian sample size calculation for estimation of the difference between two binomial proportions.Value of information and pricing new healthcare interventions.Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods.
P2860

A Bayesian cost-benefit approach to the determination of sample size in clinical trials.

Item
http://www.wikidata.org/entity/Q47283839
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
A Bayesian cost-benefit approach to the determination of sample size in clinical trials.
@en
A Bayesian cost-benefit approach to the determination of sample size in clinical trials.
@nl
type
label
A Bayesian cost-benefit approach to the determination of sample size in clinical trials.
@en
A Bayesian cost-benefit approach to the determination of sample size in clinical trials.
@nl
prefLabel
A Bayesian cost-benefit approach to the determination of sample size in clinical trials.
@en
A Bayesian cost-benefit approach to the determination of sample size in clinical trials.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
A Bayesian cost-benefit approach to the determination of sample size in clinical trials.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698